Azacitidine,venetoclax
roche,abbvie
['leusm', 'elucida']
#asco22 #leusm uy: outcomes dismal in pts relapsing or not responding to front-line aza/ven. vyxoes doesn t work well here and many of these pts are not eligible for ic so targeted inhibitors extremely important here. likelihood of resp after aza/ven fails still to be elucidated. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)